Tesa M. Severson

Amsterdam, NH 1066CX, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer.

TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 15, 2025

Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterations.

Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterations.

Journal: Genome biology

Published: June 10, 2024

Fasting boosts breast cancer therapy efficacy via glucocorticoid activation.

Fasting boosts breast cancer therapy efficacy via glucocorticoid activation.

Journal: Nature

Published: February 29, 2024

Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.

Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.

Journal: The Journal of clinical investigation

Published: December 18, 2023

Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients.

Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients.

Journal: medRxiv : the preprint server for health sciences

Published: March 03, 2023

Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer.

Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer.

Journal: Cell reports. Medicine

Published: February 24, 2023

PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription.

PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription.

Journal: Nucleic acids research

Published: January 23, 2023

Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven Programs.

Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven Programs.

Journal: European urology

Published: January 16, 2023

Double-strand break toxicity is chromatin context independent.

Double-strand break toxicity is chromatin context independent.

Journal: Nucleic acids research

Published: March 28, 2022

Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer.

Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer.

Journal: Clinical epigenetics

Published: January 26, 2022

Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.

Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.

Journal: Nature communications

Published: January 18, 2022

Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.

Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.

Journal: Nature communications

Published: August 16, 2021

Showing 1-12 of 39

Last Updated: 09/26/2026